Inventiva (IVA) Interest & Investment Income (2019 - 2022)
Inventiva (IVA) posted quarterly Interest & Investment Income of $4.47 for Q2 2025, down 100.0% year-over-year from $4.3 million in Q2 2024, and down 100.0% quarter-over-quarter from $5.6 million in Q4 2024.
Analysis
Inventiva (IVA) Interest & Investment Income (2019 - 2022) Analysis & Trends
Inventiva's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $4.47 for Q2 2025.
- In Q2 2025, Interest & Investment Income fell 100.0% year-over-year to $4.47; the TTM figure through Jun 2025 stood at $4.47 (down 100.0% YoY), while the FY2025 annual figure was $4.9 million, down 12.98% from the prior year.
- Interest & Investment Income for Q2 2025 stood at $4.47, down from $5.6 million in the prior quarter.
- The five-year high for Interest & Investment Income was $5.6 million in Q4 2024, with the low at $4.47 in Q2 2025.
- The 4-year median for Interest & Investment Income is $3.7 million (2023), against an average of $3.1 million.
- The sharpest annual moves came in 2021 and 2025: Interest & Investment Income soared 20026.9% in 2021, then tumbled 100.0% in 2025.
- Inventiva's Interest & Investment Income stood at $1.9 million in 2021, then jumped by 92.42% to $3.7 million in 2023, then surged by 52.23% to $5.6 million in 2024, then sank by 100.0% to $4.47 in 2025.
- Business Quant data shows IVA's Interest & Investment Income at $4.47 in Q2 2025, $5.6 million in Q4 2024, and $4.3 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 4.06 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 4.44 Mn |
| Dec 31, 2020 | -4.65 Mn |
| Jun 30, 2020 | 30,840.88 |
| Mar 31, 2020 | 22,078.78 |
| Dec 31, 2019 | 102,940.55 |